Lam Research Corp
NASDAQ:LRCX
Lam Research Corp
NASDAQ:LRCX
Price:
75.84
USD
-2.21%
Market Closed
Market Cap:
97.4B
USD
Balance Sheet
Balance Sheet Decomposition
Lam Research Corp
Lam Research Corp
| Current Assets | 13.6B |
| Cash & Short-Term Investments | 5.7B |
| Receivables | 3.3B |
| Other Current Assets | 4.6B |
| Non-Current Assets | 6.2B |
| PP&E | 2.3B |
| Intangibles | 1.8B |
| Other Non-Current Assets | 2.2B |
Balance Sheet
Lam Research Corp
Lam Research Corp
Currency: USD
Millions
Annual
| Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
1 502
|
5 039
|
2 378
|
4 512
|
3 658
|
4 915
|
4 418
|
3 522
|
5 337
|
5 848
|
|
| Cash Equivalents |
1 502
|
5 039
|
2 378
|
4 512
|
3 658
|
4 915
|
4 418
|
3 522
|
5 337
|
5 848
|
|
| Short-Term Investments |
2 575
|
1 789
|
3 664
|
437
|
1 773
|
1 795
|
1 311
|
136
|
38
|
0
|
|
| Total Receivables |
1 094
|
1 262
|
1 673
|
2 177
|
1 456
|
2 097
|
3 026
|
4 314
|
2 823
|
2 519
|
|
| Accounts Receivables |
1 094
|
1 262
|
1 673
|
2 177
|
1 456
|
2 097
|
3 026
|
4 314
|
2 823
|
2 519
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
943
|
972
|
1 233
|
1 876
|
1 540
|
1 900
|
2 689
|
3 966
|
4 816
|
4 218
|
|
| Other Current Assets |
157
|
151
|
195
|
148
|
133
|
146
|
208
|
347
|
214
|
298
|
|
| Total Current Assets |
6 271
|
9 213
|
9 142
|
9 150
|
8 560
|
10 854
|
11 652
|
12 285
|
13 228
|
12 883
|
|
| PP&E Net |
621
|
640
|
686
|
903
|
1 059
|
1 246
|
1 477
|
1 874
|
2 099
|
2 463
|
|
| PP&E Gross |
621
|
640
|
686
|
903
|
1 059
|
1 246
|
1 477
|
1 874
|
2 099
|
2 463
|
|
| Accumulated Depreciation |
630
|
722
|
757
|
834
|
964
|
1 083
|
1 271
|
1 440
|
1 642
|
1 861
|
|
| Intangible Assets |
728
|
565
|
411
|
318
|
217
|
169
|
132
|
102
|
168
|
139
|
|
| Goodwill |
1 388
|
1 386
|
1 386
|
1 485
|
1 485
|
1 484
|
1 490
|
1 515
|
1 622
|
1 627
|
|
| Long-Term Investments |
139
|
150
|
180
|
209
|
229
|
0
|
0
|
0
|
118
|
0
|
|
| Other Long-Term Assets |
218
|
311
|
318
|
415
|
451
|
806
|
1 140
|
1 419
|
1 545
|
1 634
|
|
| Other Assets |
1 388
|
1 386
|
1 386
|
1 485
|
1 485
|
1 484
|
1 490
|
1 515
|
1 622
|
1 627
|
|
| Total Assets |
9 365
N/A
|
12 264
+31%
|
12 123
-1%
|
12 479
+3%
|
12 001
-4%
|
14 559
+21%
|
15 892
+9%
|
17 196
+8%
|
18 782
+9%
|
18 745
0%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
300
|
348
|
465
|
511
|
377
|
592
|
830
|
1 011
|
471
|
614
|
|
| Accrued Liabilities |
408
|
432
|
609
|
699
|
464
|
570
|
774
|
767
|
803
|
809
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1 360
|
948
|
908
|
610
|
667
|
840
|
11
|
7
|
8
|
505
|
|
| Other Current Liabilities |
564
|
690
|
968
|
1 330
|
864
|
1 160
|
1 913
|
2 779
|
2 903
|
2 410
|
|
| Total Current Liabilities |
2 631
|
2 418
|
2 950
|
3 150
|
2 372
|
3 162
|
3 528
|
4 565
|
4 185
|
4 338
|
|
| Long-Term Debt |
1 243
|
3 586
|
1 955
|
1 885
|
3 872
|
4 982
|
4 990
|
4 998
|
5 003
|
4 479
|
|
| Other Liabilities |
387
|
366
|
400
|
943
|
1 084
|
1 242
|
1 347
|
1 354
|
1 383
|
1 388
|
|
| Total Liabilities |
4 262
N/A
|
6 370
+49%
|
5 305
-17%
|
5 978
+13%
|
7 327
+23%
|
9 387
+28%
|
9 865
+5%
|
10 917
+11%
|
10 571
-3%
|
10 205
-3%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
4 097
|
4 820
|
6 250
|
8 261
|
9 931
|
11 521
|
14 685
|
18 455
|
22 032
|
24 811
|
|
| Additional Paid In Capital |
5 367
|
5 573
|
5 845
|
6 144
|
6 409
|
6 696
|
7 053
|
7 415
|
7 809
|
8 225
|
|
| Unrealized Security Profit/Loss |
4
|
5
|
1
|
1
|
2
|
5
|
2
|
2
|
0
|
0
|
|
| Treasury Stock |
4 303
|
4 429
|
5 216
|
7 846
|
11 603
|
12 950
|
15 647
|
19 481
|
21 530
|
24 367
|
|
| Other Equity |
54
|
74
|
63
|
56
|
66
|
99
|
66
|
108
|
100
|
130
|
|
| Total Equity |
5 103
N/A
|
5 895
+16%
|
6 817
+16%
|
6 502
-5%
|
4 674
-28%
|
5 172
+11%
|
6 027
+17%
|
6 278
+4%
|
8 210
+31%
|
8 539
+4%
|
|
| Total Liabilities & Equity |
9 365
N/A
|
12 264
+31%
|
12 123
-1%
|
12 479
+3%
|
12 001
-4%
|
14 559
+21%
|
15 892
+9%
|
17 196
+8%
|
18 782
+9%
|
18 745
0%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
159
|
160
|
162
|
157
|
144
|
145
|
143
|
137
|
133
|
1 304
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
